CATALAYER NEWS
Johnson & Johnson wins FDA approval for Rybrevant cancer treatment
Source: Investing.com · 2026-11-06
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Chime Financial co-founder Ryan King sells $1.98M in stock
2026-11-07
China extends gold buying streak to 24 months as prices slump below $4,000
2026-11-07
SharkNinja CEO Mark Barrocas sells $25 million in company shares
2026-11-07
Ryerson Holding evp Andrew Greiff sells $96,300 in common stock
2026-11-07
Russia launches ballistic missile attack on Kyiv ahead of Abu Dhabi peace talks
2026-11-07
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets